Tenapanor Scores FDA Advisory Committee Endorsement
An FDA advisory committee said the benefits of tenapanor for treating hyperphosphatemia in patients on dialysis outweighed its risks as both mono- and combo-therapy.
Source: medscape.com
Page 14 - Vascular Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Vascular Access Today - Breaking & Trending Today
Dialysis Not Always Best Option in Advanced Kidney Disease
Hospitalization rates were higher in advanced chronic kidney disease (CKD) patients treated with dialysis than those managed conservatively over 2 years of follow-up
Source: medscape.com
Study Sheds New Light on RAS Inhibitors' Role for Advanced CKD
Maintaining treatment with a renin-angiotensin system inhibitor in people with advanced, progressive chronic kidney disease caused no problems compared with stopping it in a randomized study.
Source: medscape.com
Liverpool cancer nurse's innovation goes global
An innovative project launched by a clinical nurse specialist has “transformed” the way patients receive cancer treatment and has been recognised on a
Source: nursingtimes.net
Terlipressin Decreases Need for RRT in Liver Transplant Patients
The drug restores renal blood flow and reverses hepatorenal syndrome type 1 in some patients.
Source: medscape.com